Smokers who seek help in specialized cessation clinics: How special are they compared to smokers in general population?

Journal of Smoking Cessation

Volumn 9, Issue 2, 2013, Pages 76-84

  Samokhvalov, Andriy V ^a,b   Selby, Peter ^b,c   Bondy, Susan J ^b   Chaiton, Michael ^a,b   Ialomiteanu, Anca ^a   Mann, Robert ^a,b   Rehm, Jürgen ^a,b,d  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

clinical populations; Nicotine dependence; smoking cessation; treatment seeking

Indexed keywords

EID: 84988046573     PISSN: None     EISSN: 18342612     Source Type: Journal    
DOI: 10.1017/jsc.2013.23     Document Type: Article

References (30)

1. Abrams, D. B., Orleans, C. T., Niaura, R., Goldstein, M. G., Prochaska, J. O., & Velicer,W. (1996). Integrating individual and public health perspectives for treatment of tobacco dependence under managed health care: A combined steppedcare and matching model. Annals of Behavioral Medicine, 18(4), 290-304.
2. Bertholet, N., Gaume, J., Faouzi,M., Gmel, G., & Daeppen, J. B. (2012). Predictive value of readiness, importance, and confidence in ability to change drinking and smoking. BMC Public Health, 12, 708. doi: doi: 10.1186/1471-2458-12- 708
3. Bobak, M., Jha, P., Nguyen, S., & Jarvis, M. (2000). Poverty and smoking. Tobacco control in developing countries: Oxford Medical Publications.
4. Bulter-Jones,D. (2008). The Chief PublicHealth Officers Report on The State of PublicHealth in Canada 2008. Ottawa: Public Health Agency of Canada.
5. Cahill, K., Stead, L. F., & Lancaster, T. (2012). Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews(4). doi:10.1002/14651858. CD006103.pub6
6. Coe, J. W., Rollema, H., & ONeill, B. T. (2009). Case history: ChantixTM/ChampixTM (Varenicline Tartrate), a nicotinic acetylcholine receptor partial agonist as a smoking cessation aid. Annual Reports in Medicinal Chemistry, 44, 71-101.
7. Cummins, S. E.,Bailey, L., Campbell, S.,Koon-Kirby, C.,&Zhu, S. (2007). Tobacco cessation quitlines in North America: A descriptive study. Tobacco Control, 16(Suppl 1), i9-15.
8. Diemert, L., Victor, J. C., Chaiton, M., & Bondy, S. J. (2010). Ontario Tobacco Survey Technical Report 1:Baseline Data. Toronto, ON: Ontario Tobacco Research Unit.
9. Doran, C. M., Valenti, L., Robinson, M., Britt, H., & Mattick, R. P. (2006). Smoking status of Australian general practice patients and their attempts to quit. Addictive Behaviours, 31, 758-766.
10. Fagerstrom, K., Russ, C., Yu, C. R., Yunis, C., & Foulds, J. (2012). The Fagerstrom Test for Nicotine Dependence as a predictor of smoking abstinence: A pooled analysis of varenicline clinical trial data. Nicotine and Tobacco Research.
11. Hammond, D., McDonald, P. W., Fong, G. T., & Borland, R. (2004). Do smokers know how to quit? Knowledge and perceived effectiveness of cessation assistance as predictors of cessation behaviour. Addiction, 99(8), 1042-1048.
12. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerstrom, K. O. (1991). The Fagerstrom Test for Nicotine Dependence: Arevision of the FagerstromToleranceQuestionnaire. British Journal of Addiction, 86, 1119-1127.
13. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., Rickert, W., & Robinson, J. (1989). Measuring the heaviness of smoking: Using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. British Journal of Addiction, 7, 791-800.
14. Hughes, J. R., Stead, L. F., & Lancaster, T. (2007). Antidepressants for smoking cessation. CochraneDatabase of Systematic Reviews(1). doi: 10.1002/14651858.CD000031.pub3
15. Ialomiteanu, A., & Adlaf, E. A. (2012). CAMH Monitor 2011: Metadata Users eGuide. Toronto, Ontario: Centre for Addiction and Mental Health
16. Klingemann, H., Sobell, M. B., & Sobell, L. C. (2009). Continuities and changes in self-change research. Addiction. doi: Doi: 10.1111/j.1360-0443.2009.02770.x
17. Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., ⋯ Aryee,M. (2013). A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. The Lancet, 380(9859), 2224-2260.
18. McCaul, K. D., Hockemeyer, J. R., Johnson, R. J., Zetocha, K., Quinlan, K., & Glasgow, R. E. (2006). Motivation to quit using cigarettes: A review. Addiictive Behaviour, 31, 42-56.
19. Miller,W. R., & Rollnick, S. (2002).Motivational Interviewing.In Preparing People for Change. 2nd edition.New York, NY: The Guilford Press.
20. Niaura, R.,&Abrams,D. B. (2002). Smoking cessation: progress, priorities and prospectus. Journal of Consulting and Clinical Psychology, 70(3), 494-509.
21. Okechukwu, C. A., Nguyen, K., & Hickman, N. J. (2010). Partner smoking characteristics: Associations with smoking and quitting among blue collar apprentices. American Journal of Industrial Medicine, 53(11), 1102-1108.
22. Prochaska, J. O., & Goldstein, M. G. (1991). Process of smoking cessation. Implications for clinicians. Clinics In Chest Medicine, 12(4), 727-735.
23. Rehm, J.,Gnam,W., Popova, S., Baliunas,D., Brochu, S., Fischer, B., ⋯ Taylor, B. (2007). The costs of alcohol, illegal drugs, and tobacco in Canada, 2002. Journal of Studies on Alcohol and Drugs, 68(6), 886.
24. Reid, J., Hammond, D., Burkhalter, R., & Ahmed, R. (2012). Tobacco Use in Canada: Patterns and Trends, 2012 Edition. Waterloo, ON: Propel Centre for Population Health Impact. University of Waterloo.
25. Selby, P., Voci, S. C., Zawertailo, L. A., George, T. P., & Brands, B. (2010). Individualized smoking cessation treatment in an outpatient setting: Predictors of outcome in a sample with psychiatric and addictions co-morbidity.. Addictive Behaviors, 811-817. doi: 10.1016/j.addbeh.2010.03.020
26. Stead, L. F., & Lancaster, T. (2012). Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database of Systematic Reviews(10). doi: 10.1002/14651858.CD008286.pub2
27. Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2012). Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews(11). doi: 10.1002/14651858.CD000146. pub4
28. Williams, J. M., & Ziedonis, D. (2004). Addressing tobacco among individuals with a mental illness or an addiction. Addictive Behaviors, 29(6), 1067-1083.
29. Woolacott, N., Jones, L., Forbes, C., Mather, L., Sowden, A., Song, F., ⋯ Barton, P. (2002). The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: A systematic review and economic evaluation. Health Technology Assessment, 6(16), 245pp.
30. Zhu, S., Melcer, T., J., S., Rosbrook, B., & Pierce, J. P. (2000). Smoking cessation with and without assistance: A population-based analysis. American Journal of Preventive Medicine, 18, 305-311.